Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Sept 2026 for Crinetics Pharmaceuticals, Inc., €122k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Isabel Kalofonos: trading record in brief
Isabel Kalofonos, listed as senior executive, appears in our data through filings on Crinetics Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 5 January 2026 and the latest from 1 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 1 September 2026: a transaction of €122k, in Crinetics Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Isabel Kalofonos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,669 shares@ US$85.000.0015% mcap4.5% of flowCommon StockSEC:0001628280-26-059885:0
34,000 shares@ US$85.000.031% mcap92.3% of flowCommon StockSEC:0001628280-26-059885:1
34,000 shares0Common StockSEC:0001628280-26-011715:0
2,500 shares@ US$40.590.0011% mcap3.2% of flowCommon StockSEC:0001628280-26-001230:0
4 of 4 declarations
